Inozyme Pharma to Provide ENPP1 Deficiency Program Update on July 26, 2023
– Conference call and webcast to be held on July 26, 2023, at 8am ET – BOSTON, July 19, 2023...
Clinical Trial
Tenax Therapeutics Issued U.S. Patent for Oral Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
New U.S. patent provides intellectual property (IP) protection until December 2040, and may qualify for term extension beyond 2040There are...
First Wave BioPharma, Inc. Announces Pricing of $2.1 Million Public Offering
BOCA RATON, Fla., July 19, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”),...
Akari Therapeutics Appoints Experienced Life Sciences Executive Wendy DiCicco as Interim Chief Financial Officer
NEW YORK and LONDON, July 19, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing...
Emergex Reports Promising Data from Completed Swiss Phase I Trial of CoronaTcP™, T Cell-Priming Immune Set-Point Candidate for Betacoronaviruses
First-in-human intradermal administration of CoronaTcP™ was generally well-toleratedEvidence for generation of virus-specific effector and memory CD8+ T cellsData reinforce findings...
Rhythm Pharmaceuticals Announces Two Publications Detailing Burden of Hyperphagia and Obesity on Patients and Caregivers Living with Bardet-Biedl Syndrome
Results of The CAREgiver Burden in BBS (CARE-BBS) study show multifaceted burden of hyperphagiaBOSTON, July 19, 2023 (GLOBE NEWSWIRE) --...
HealthTab™ to Integrate CONTOUR®NEXT Family of Blood Glucose Meters to Offer Deeper Diabetes Patient Insights
VANCOUVER, British Columbia, July 19, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”)...
MindBio Therapeutics World First Phase 2 Take-Home LSD-Microdosing Clinical Trial in Patients with Major Depressive Disorder Begins Pre-Screening Participants
Patients meeting the selection criteria are currently being pre-screened for entry into the Phase 2 Depression trialEthics and clinical trials...
Biophytis Announces $3.8 Million Registered Direct Offering
PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / July 19, 2023 / Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis"...
Applied DNA Biotherapeutics Subsidiary LineaRx to Participate in Upcoming mRNA Industry Conferences
STONY BROOK, NY / ACCESSWIRE / July 18, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA"), a leader in...
Aptevo Announces Positive Duration of Remission Data from Phase 1b Expansion Trial Evaluating the Bispecific APVO436 for AML
Phase 2 Trials in Relapsed/Refractory and Frontline Settings Planned, APVO436 to be administered in Combination with Emerging Standard of CareNew...
NeoGenomics to Report Second Quarter 2023 Financial Results on August 8, 2023
FT. MYERS, FL / ACCESSWIRE / July 18, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and...
Celularity Human Placental-Derived Advanced Biomaterials Demonstrate Superior Biocompatibility and Better Support Differentiated Cell Functions in Studies
Celularity will present benchtop and clinical case studies suggesting the therapeutic potential of its human placental-derived biomaterials at ICBST23, the...
BioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use Disorder
ANAHEIM, CA, July 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and...
Cepham’s Prosprune Protects Men and Sustains the Environment in the Name of Prostate Health
Developing Prosprune® Recognizing the need for an alternative to the endangered Pygeum africanum, the research team at Cepham analyzed various...
Revolo Biotherapeutics Announces Additional Data from Phase 2a Trial of ‘1104 in Adults with Active Eosinophilic Esophagitis
- Data shows statistically significant improvement in patient-reported dysphagia symptoms compared to placebo - - Unique broad mechanistic effect across...
BioHarvest Sciences Inc. Announces Closing of Private Placement of Convertible Notes
This press release does not constitute an offer to sell or a solicitation to buy any securities in any jurisdiction.Vancouver,...
Biophytis and SEQENS Sign a Partnership to Produce Sarconeos (BIO101) Active Compound
PARIS, FRANCE / ACCESSWIRE / July 18, 2023 / Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis"), a clinical-stage biotechnology...
Glaukos Enters into a Collaboration and Marketing Agreement with Radius XR, Inc.
Advancing Next-Generation Wearable Patient Engagement and Diagnostic Technology Designed to Enable More Efficient Detection of Eye DiseasesALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos...
STEMTECH (OTCQB: STEK) Shatters Records with Surge in New Recruits, Paving the Way for a Thrilling Era of Opportunity in the Booming Global Stem Cell Market
Growth Sparks Excitement as STEMTECH Achieves Record-Breaking Surge in New Independent Business PartnersMIRAMAR, FL / ACCESSWIRE / July 17, 2023...